interferon inducers

Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia
Weiyi Wang, Shuaitong Liu, Peihong Dai, Ning Yang, Yi Wang, Rachel A Giese, Taha Merghoub, Jedd Wolchok, Liang Deng

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002569; DOI: 10.1136/jitc-2021-002569
Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors
Shirley Tenesaca, Marcos Vasquez, Maite Alvarez, Itziar Otano, Myriam Fernandez-Sendin, Claudia Augusta Di Trani, Nuria Ardaiz, Celia Gomar, Angela Bella, Fernando Aranda, José Medina-Echeverz, Ignacio Melero, Pedro Berraondo

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e001587; DOI: 10.1136/jitc-2020-001587
Oncolytic parainfluenza virus combines with NK cells to mediate killing of infected and non-infected lung cancer cells within 3D spheroids: role of type I and type III interferon signaling
Namita Varudkar, Jeremiah L Oyer, Alicja Copik, Griffith D Parks

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002373; DOI: 10.1136/jitc-2021-002373
STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer
Seung Joon Lee, Hannah Yang, Woo Ram Kim, Yu Seong Lee, Won Suk Lee, So Jung Kong, Hye Jin Lee, Jeong Hun Kim, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Chan Kim

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002195; DOI: 10.1136/jitc-2020-002195
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression
Marina Natoli, John Gallon, Haonan Lu, Ala Amgheib, David J Pinato, Francesco A Mauri, Teresa Marafioti, Ayse U Akarca, Ines Ullmo, Jacey Ip, Eric O Aboagye, Robert Brown, Anastasios Karadimitris, Sadaf Ghaem-Maghami

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001519; DOI: 10.1136/jitc-2020-001519
Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1–mediated immunoescape via STING-IFN signaling and extracellular vesicles
An Ning Cheng, Li-Chun Cheng, Cheng-Liang Kuo, Yu Kang Lo, Han-Yu Chou, Chung-Hsing Chen, Yi-Hao Wang, Tsung-Hsien Chuang, Shih-Jung Cheng, Alan Yueh-Luen Lee

Journal for ImmunoTherapy of Cancer Dec 2020, 8 (2) e001372; DOI: 10.1136/jitc-2020-001372
Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse
Marion v Guerin, Fabienne Regnier, Maxime Thoreau, Lene Vimeux, Matthieu Benard, Estelle Dransart, Hweixian L Penny, Ludger Johannes, Alain Trautmann, Nadege Bercovici

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e000996; DOI: 10.1136/jitc-2020-000996
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy
Christianne Groeneveldt, Priscilla Kinderman, Diana J M van den Wollenberg, Ruben L van den Oever, Jim Middelburg, Dana A M Mustafa, Rob C Hoeben, Sjoerd H van der Burg, Thorbald van Hall, Nadine van Montfoort

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001191; DOI: 10.1136/jitc-2020-001191
BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy
Madhuri Koti, Alvaro Morales, Charles H Graham, David Robert Siemens

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e001119; DOI: 10.1136/jitc-2020-001119
Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages
Lydia Meziani, Marine Gerbé de Thoré, Pauline Hamon, Sophie Bockel, Ruy A Louzada, Céline Clemenson, Raphaël Corre, Winchygn Liu, Corinne Dupuy, Michele Mondini, Eric Deutsch

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000622; DOI: 10.1136/jitc-2020-000622

Log in using your username and password

Main menu

Log in using your username and password

You are here

interferon inducers